How can protein aggregation in Parkinson’s lead to neurodegeneration?
- 演題
- How can protein aggregation in Parkinson’s lead to neurodegeneration?
- 講演者
- Dr. Harvey T. McMahon ( MRC Laboratory of Molecular Biology, Cambridge UK )
- 使用言語
- English
- 日時
- 2022年11月29日(火曜日) 15:30~16:30
- 場所
- Rethink Biological Science Seminar Hall (L11)
- 内容
- Protein aggregates are associated with many neurodegenerative diseases such as Alzheimer’s and Parkinson’s. While there is considerable evidence for protein aggregates being toxic, the molecular details and mechanism of toxicity/neurodegeneration are ambiguous. Is it the aggregate itself or the deleterious loss of an important physiological function of a protein when it aggregates? I will present data investigating these possibilities using the protein a-Synuclein found to be aggregated in Synucleinopathies.
We will also explore what might be the physiological function of alpha-synuclein and thus how this may be altered in disease. Overall, I would like to encourage discussion around what might be useful strategies for early interventions for disease therapy. - 問合せ先
- Molecular Medicine and Cell Biology
Suetsugu Shiro (suetsugu@bs.naist.jp)